Hasnain Faheem Insider Trading
Get the latest insider transactions of Hasnain Faheem. Hasnain Faheem is EVP, Oncology/Rheumatology SBU in BIOGEN INC. ($IDPH) and SVP, Oncology SBU in BIOGEN INC. ($IDPH) and Director in VITAL THERAPIES INC ($VTL) and Director in Tocagen Inc ($TOCA) and Director in Kura Oncology, Inc. ($KURA) and President & CEO in Receptos, Inc. ($RCPT) and in Mirati Therapeutics, Inc. ($MYG) and Director in Gossamer Bio, Inc. ($GOSS) and Executive Chairman in Gossamer Bio, Inc. ($GOSS) and President & CEO in Gossamer Bio, Inc. ($GOSS) and Director in Nuvation Bio Inc. ($PANA). Discover the current value of Hasnain Faheem shares.
Address: 14 CAMBRIDGE CENTER CAMBRIDGE 02142MA
Hasnain Faheem is Insider in these Companies
| Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
|---|---|---|---|---|
| IDPH | BIOGEN INC. | EVP, Oncology/Rheumatology SBU, SVP, Oncology SBU | 25,454 | 0.00 |
| RCPT | Receptos, Inc. | President & CEO | 0 | 0.00 |
| KURA | Kura Oncology, Inc. | Director | 0 | 0.00 |
| VTL | IMMUNIC, INC. | Director | 122,743 | 570,754.95 |
| TOCA | Forte Biosciences, Inc. | Director | 241,717 | |
| GOSS | Gossamer Bio, Inc. | President & CEO, Director, Executive Chairman | 162,500 | |
| MYG | Mirati Therapeutics, Inc. | 5,098 | 0.00 | |
| NUVB | Nuvation Bio Inc. | Director | 25,000 |
Insider Trading Transactions of Hasnain Faheem
| Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2021 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 21.54 | 23,000 | 495,420 | 23,000 |
| Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | President & CEO | Buy | 0.00 | 162,500 | 0 | 162,500 |
| Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | President & CEO | Option Exercise | 9.79 | 325,000 | 3,181,750 | 325,000 |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Hasnain Faheem | Director | Buy | 0.00 | 25,000 | 0 | 25,000 |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Hasnain Faheem | Director | Buy | 10.00 | 30,000 | 300,000 | 55,000 |
| Feb 26 2021 | PANA | Nuvation Bio Inc. | Hasnain Faheem | Director | Option Exercise | 0.00 | 25,000 | 0 | 0 |
| Jan 20 2021 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Buy | 0.00 | 2,098 | 0 | 5,098 | |
| Jan 20 2021 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Option Exercise | 214.47 | 3,064 | 657,136 | 3,064 | |
| Jun 26 2020 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 17.97 | 23,000 | 413,310 | 23,000 |
| Jun 18 2020 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Director | Option Exercise | 12.10 | 47,000 | 568,700 | 47,000 |
| Jan 07 2020 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Buy | 0.00 | 3,000 | 0 | 3,000 | |
| Jan 07 2020 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Option Exercise | 113.20 | 6,000 | 679,200 | 6,000 | |
| Jan 07 2020 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Buy | 0.00 | 3,000 | 0 | 3,000 | |
| Jan 07 2020 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Option Exercise | 113.20 | 6,000 | 679,200 | 6,000 | |
| Oct 04 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | 0.64 | 7,500 | 4,793 | 7,500 |
| Oct 04 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | 0.64 | 7,500 | 4,793 | 7,500 |
| Sep 27 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Director | Buy | 16.80 | 10,000 | 167,980 | 3,382,109 |
| Jun 27 2019 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 19.55 | 13,000 | 254,150 | 13,000 |
| Jun 03 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | 4.59 | 38,860 | 178,414 | 241,717 |
| Jun 03 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | 5.30 | 3,890 | 20,613 | 245,607 |
| Jun 03 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | 5.15 | 250 | 1,287 | 245,857 |
| May 31 2019 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | 4.22 | 20,000 | 84,400 | 20,000 |
| Mar 26 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Option Exercise | 22.10 | 43,500 | 961,350 | 43,500 |
| Feb 20 2019 | MYG | Mirati Therapeutics, Inc. | Hasnain Faheem | Option Exercise | 72.62 | 47,000 | 3,413,140 | 47,000 | |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Buy | 0.00 | 58,599 | 0 | 3,372,109 |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Option Exercise | 0.00 | 185,984 | 0 | 0 |
| Feb 12 2019 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | Executive Chairman | Option Exercise | 0.00 | 77,719 | 0 | 0 |
| Sep 17 2018 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Sell | 0.44 | 59,200 | 25,912 | 122,743 |
| Sep 17 2018 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Sell | 0.44 | 118,243 | 51,767 | 4,500 |
| Sep 17 2018 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Sell | 0.44 | 59,200 | 25,912 | 122,743 |
| Sep 17 2018 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Sell | 0.44 | 118,243 | 51,767 | 4,500 |
| Jun 25 2018 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | 8.98 | 20,000 | 179,600 | 20,000 |
| Jun 08 2018 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 16.35 | 13,000 | 212,550 | 13,000 |
| May 25 2018 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Option Exercise | 6.10 | 41,353 | 252,253 | 41,353 |
| Sep 15 2017 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Buy | 4.19 | 59,200 | 247,870 | 181,943 |
| Sep 06 2017 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Option Exercise | 3.15 | 15,222 | 47,949 | 15,222 |
| Jun 12 2017 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 8.60 | 10,000 | 86,000 | 10,000 |
| May 25 2017 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Option Exercise | 3.20 | 45,022 | 144,070 | 45,022 |
| Apr 21 2017 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | 10.00 | 102,857 | 1,028,570 | 102,857 |
| Apr 21 2017 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Buy | 10.00 | 100,000 | 1,000,000 | 202,857 |
| Apr 12 2017 | TOCA | Tocagen Inc | Hasnain Faheem | Director | Option Exercise | 10.00 | 10,869 | 108,690 | 10,869 |
| Aug 15 2016 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Buy | 5.92 | 118,243 | 699,999 | 122,743 |
| Aug 15 2016 | VTL | VITAL THERAPIES INC | Hasnain Faheem | Director | Option Exercise | 5.92 | 58,574 | 346,758 | 58,574 |
| May 13 2016 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 3.12 | 10,000 | 31,200 | 10,000 |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hasnain Faheem | President & CEO | Sell | 0.00 | 384,409 | 0 | 32,500 |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hasnain Faheem | President & CEO | Sell | 0.00 | 32,500 | 0 | 0 |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hasnain Faheem | President & CEO | Option Exercise | 8.10 | 133,333 | 1,079,997 | 0 |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hasnain Faheem | President & CEO | Option Exercise | 18.77 | 143,500 | 2,693,495 | 0 |
| Aug 27 2015 | RCPT | Receptos, Inc. | Hasnain Faheem | President & CEO | Option Exercise | 41.51 | 106,107 | 4,404,502 | 0 |
| Apr 27 2015 | KURA | Kura Oncology, Inc. | Hasnain Faheem | Director | Option Exercise | 6.32 | 30,000 | 189,600 | 30,000 |
| Apr 03 2015 | RCPT | Receptos, Inc. | Hasnain Faheem | President & CEO | Buy | 0.00 | 32,500 | 0 | 416,909 |
| Jul 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Buy | 44.24 | 20,450 | 904,708 | 52,566 |
| Jul 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Buy | 49.31 | 9,725 | 479,540 | 62,291 |
| Jul 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 61.71 | 21,037 | 1,298,105 | 41,254 |
| Jul 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 62.56 | 15,800 | 988,500 | 25,454 |
| Jul 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Option Exercise | 44.24 | 20,450 | 904,708 | 20,450 |
| Jul 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Option Exercise | 49.31 | 9,725 | 479,540 | 29,175 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 63.71 | 100 | 6,371 | 38,441 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 63.79 | 200 | 12,758 | 38,241 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 63.89 | 200 | 12,778 | 38,041 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 63.93 | 100 | 6,393 | 37,941 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.18 | 300 | 19,254 | 37,641 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.32 | 500 | 32,160 | 37,141 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.38 | 400 | 25,752 | 36,741 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.39 | 2 | 129 | 36,739 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.40 | 200 | 12,880 | 36,539 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.42 | 998 | 64,291 | 35,541 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.44 | 800 | 51,552 | 34,741 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.48 | 25 | 1,612 | 34,716 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.51 | 300 | 19,353 | 34,416 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.54 | 100 | 6,454 | 34,316 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.58 | 100 | 6,458 | 34,216 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.61 | 100 | 6,461 | 34,116 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.63 | 300 | 19,389 | 33,816 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.64 | 100 | 6,464 | 33,716 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.67 | 100 | 6,467 | 33,616 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.72 | 300 | 19,416 | 33,316 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.79 | 400 | 25,916 | 32,916 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.82 | 400 | 25,928 | 32,516 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.92 | 100 | 6,492 | 32,416 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.93 | 200 | 12,986 | 32,216 |
| Apr 10 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 64.94 | 100 | 6,494 | 32,116 |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 60.56 | 1,788 | 108,281 | 27,647 |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Buy | 0.00 | 10,430 | 0 | 38,077 |
| Feb 14 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Option Exercise | 60.56 | 29,210 | 1,768,958 | 29,210 |
| Feb 07 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Buy | 0.00 | 5,467 | 0 | 31,452 |
| Feb 07 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Sell | 60.52 | 2,017 | 122,069 | 29,435 |
| Feb 07 2008 | IDPH | BIOGEN INC. | Hasnain Faheem | EVP, Oncology/Rheumat ... | Option Exercise | 0.00 | 5,467 | 0 | 5,466 |
| Nov 02 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Buy | 0.00 | 2,700 | 0 | 25,918 |
| Nov 02 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Option Exercise | 72.87 | 6,900 | 502,803 | 6,900 |
| Oct 09 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 65.88 | 3,575 | 235,521 | 23,011 |
| May 24 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 49.00 | 7,446 | 364,854 | 25,897 |
| Mar 16 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Buy | 0.00 | 6,225 | 0 | 35,569 |
| Mar 16 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.11 | 2,226 | 98,189 | 33,343 |
| Mar 16 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Buy | 0.00 | 6,225 | 0 | 35,569 |
| Mar 16 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.11 | 2,226 | 98,189 | 33,343 |
| Feb 14 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Buy | 0.00 | 15,000 | 0 | 29,344 |
| Feb 14 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Option Exercise | 49.31 | 38,900 | 1,918,159 | 38,900 |
| Feb 08 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Buy | 0.00 | 5,467 | 0 | 16,364 |
| Feb 08 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 48.94 | 2,020 | 98,859 | 14,344 |
| Feb 08 2007 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Option Exercise | 0.00 | 5,467 | 0 | 10,933 |
| Oct 03 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.55 | 2,000 | 89,100 | 20,037 |
| Oct 03 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.58 | 1,500 | 66,870 | 18,537 |
| Oct 03 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.60 | 1,500 | 66,900 | 17,037 |
| Oct 03 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.63 | 3,000 | 133,890 | 14,037 |
| Oct 03 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 44.70 | 3,244 | 145,007 | 10,793 |
| Sep 15 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Buy | 0.00 | 17,500 | 0 | 28,203 |
| Sep 15 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Sell | 43.39 | 6,256 | 271,448 | 21,947 |
| Feb 08 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Option Exercise | 44.24 | 40,900 | 1,809,416 | 40,900 |
| Feb 08 2006 | IDPH | BIOGEN INC. | Hasnain Faheem | SVP, Oncology SBU | Option Exercise | 0.00 | 16,400 | 0 | 16,400 |